The memory ameliorating effects of novel N-benzyl pyridine-2-one derivatives on scopolamine-induced cognitive deficits in mice.
Lab Anim Res
; 40(1): 9, 2024 Mar 11.
Article
en En
| MEDLINE
| ID: mdl-38468315
ABSTRACT
BACKGROUND:
Alzheimer's disease (AD), the most common form of progressive dementia in the elderly, is a chronic neurological disorder that decreases cognitive ability. Although the underlying cause of AD is yet unknown, oxidative stress and brain acetylcholine shortage are the key pathogenic causes.RESULTS:
The current study shows that these derivatives have the potential to improve memory in mice by inhibiting scopolamine-induced acetylcholinesterase activity, oxidative and nitrosative stress, and improving locomotor activity and muscle grip strength in the rota rod test. When compared to the illness control, the memory-enhancing potential of novel N-benzyl pyridine-2-one derivatives was highly significant (P < 0.0001).CONCLUSIONS:
The observed memory ameliorating effect of novel N-benzyl pyridine-2-one makes them as a a good choice for treatment of individuals with cognitive impairment.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
Lab Anim Res
Año:
2024
Tipo del documento:
Article
País de afiliación:
India